By Anna Fenech, Pharmacist Independent Prescriber and Founder of Direct Weight Loss
If you have been looking into Mounjaro for weight loss, you have probably seen plenty of claims about how much weight people can lose with it. What is less often explained is what Mounjaro is actually doing inside the body, why the dose is increased gradually, and why some people notice a change in appetite before they see a dramatic change on the scales.
Mounjaro contains tirzepatide, a prescription medicine that acts on two hormone receptors involved in appetite, food intake and blood sugar regulation: GLP-1 and GIP.
In my work as a prescribing pharmacist, one of the most common questions I hear is, “How does it actually make me lose weight?” The short answer is that tirzepatide changes several of the signals involved in hunger and fullness. People generally feel less hungry, become satisfied with smaller portions and may find that cravings and persistent thoughts about food become much easier to manage.
But there is more to it than appetite suppression.
What is Mounjaro?
Mounjaro is the brand name for tirzepatide, a once-weekly injectable medicine licensed in the UK for weight management as well as the treatment of type 2 diabetes.
For weight management, the UK licence covers adults with a BMI of 30 kg/m² or above, or adults with a BMI of 27 kg/m² or above who also have at least one weight-related health condition, such as high blood pressure, abnormal blood lipids, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes. It is intended to be used alongside a reduced-calorie diet and increased physical activity.
Mounjaro is sometimes described simply as a “weight loss injection”. That description is understandable, but it misses an important point: tirzepatide works by acting on the body’s own hormone signalling systems.
How does Mounjaro work for weight loss?
Mounjaro is a dual GIP and GLP-1 receptor agonist.
That means tirzepatide activates receptors for two naturally occurring hormones:
- GLP-1 (glucagon-like peptide-1)
- GIP (glucose-dependent insulinotropic polypeptide)
Both hormones are involved in regulating food intake and glucose metabolism. Tirzepatide’s combined action affects appetite, satiety and blood sugar control.
1. It reduces hunger
This is usually the change patients notice first.
Mounjaro acts on areas involved in appetite regulation, helping reduce the drive to eat. You may still enjoy food, but the constant feeling that you need to eat something can become much quieter.
Some patients describe it as being able to walk past the kitchen without automatically thinking about what they could eat. Others notice that they are simply not thinking about food as often.
That distinction matters. Mounjaro is not designed to make you feel ill every time you eat. The aim is to make appetite easier to manage.
2. It helps you feel full sooner
Tirzepatide also slows gastric emptying, particularly after the early doses. In practical terms, food can remain in the stomach for longer, contributing to a greater feeling of fullness after eating.
This is one reason portion sizes often reduce naturally.
A meal that previously felt like a normal portion may suddenly feel like too much. Eating beyond that point can leave you uncomfortably full, so learning to recognise the new sensation of satiety is important.
This is also why I advise patients not to force themselves to finish a meal simply because it is on the plate.
3. It affects blood sugar and insulin
GLP-1 and GIP are involved in the body’s response to food.
Tirzepatide increases insulin secretion in a glucose-dependent manner and reduces glucagon secretion when blood glucose is elevated. This helps improve blood glucose regulation.
For someone using Mounjaro primarily for weight management, you may not notice this mechanism directly. However, improved metabolic control is part of the medicine’s overall effect.
If you are taking other medicines for diabetes, particularly insulin or a sulfonylurea, your prescriber needs to know because the risk of hypoglycaemia can be increased when these medicines are combined.
Does Mounjaro suppress your appetite completely?
No, and it should not.
One of the misconceptions I come across is that a successful treatment should make someone completely uninterested in food. That is not the goal.
You should still be able to eat. You should still enjoy meals. The difference is that hunger and cravings may become considerably easier to manage.
The response also varies from person to person. Some people notice a substantial reduction in appetite at the starting dose. Others notice relatively little initially and see a greater effect as the dose is gradually increased.
That is one reason I would not judge whether Mounjaro is “working” after the first week or two.
How quickly does Mounjaro work?
Mounjaro is not intended to produce rapid weight loss from the first injection.
The starting dose is 2.5 mg once a week. After four weeks, it is normally increased to 5 mg once weekly. If further treatment is appropriate, the dose can be increased in 2.5 mg steps, with at least four weeks spent on the current dose before another increase. The maximum recommended dose is 15 mg once weekly.
This gradual approach is deliberate.
Weeks 1–4: getting used to Mounjaro
At 2.5 mg, the priority is generally tolerability rather than trying to achieve maximum weight loss.
You may notice:
- reduced hunger
- getting full more quickly
- smaller portions
- fewer cravings
- some change in food preferences
You may also experience nausea, constipation, diarrhoea, indigestion or other gastrointestinal symptoms, particularly while your body adjusts to treatment. Gastrointestinal side effects were the most common adverse events in clinical trials and were seen particularly during dose escalation.
Some people lose weight during the first month; others lose very little. Neither response tells us exactly what will happen over the following months.
Weeks 5–8: assessing the response
Once you move to 5 mg, the appetite effect may become more noticeable.
This is often the point at which patients start saying that they can leave food on their plate without feeling deprived, or that they are naturally eating smaller meals.
It is also important not to rush the next dose increase simply because the scales have not moved as quickly as expected. If appetite is controlled and the medicine is well tolerated, your prescriber will consider your overall response rather than using one week’s weight as the deciding factor.
After the first two months
As treatment continues, some people require a higher dose to maintain the appetite effect and continue progressing towards their weight-management goals.
Others achieve good appetite control at a lower dose.
There is no prize for reaching 15 mg as quickly as possible. The appropriate dose is the one that provides a suitable balance between benefit and tolerability for the individual patient, within the licensed dosing schedule.
How much weight can you lose with Mounjaro?
There is no single amount of weight that everyone should expect to lose.
Clinical trial results give us a useful idea of what tirzepatide can achieve across a large population, but they cannot predict an individual’s result.
In the 72-week SURMOUNT-1 trial, adults with obesity or overweight plus a weight-related health condition, but without diabetes, received tirzepatide alongside lifestyle intervention. Average weight reductions were approximately 15% with 5 mg, 19.5% with 10 mg and 20.9% with 15 mg at 72 weeks.
Those are averages, not promises.
For example, someone weighing 100 kg who loses 15% of their starting weight would lose around 15 kg. Someone else taking the same dose could lose less or more.
Weight loss also tends not to happen in a perfectly straight line. You may have a week when your weight barely changes, followed by a larger drop the following week. Fluid levels, bowel movements, menstrual cycles, sodium intake and changes in activity can all affect what appears on the scales.
I therefore look at the trend over time rather than reacting to every individual weigh-in.
What does Mounjaro feel like?
This is a question patients often want answered before they start.
There is no single “Mounjaro feeling”.
Some people notice appetite reduction within days. Others describe a gradual change over several weeks. You may find that you become full after half the meal you would previously have eaten.
You may also notice that certain rich or greasy foods are less appealing. If you continue eating large portions, particularly high-fat meals, you may be more likely to experience nausea, reflux or uncomfortable fullness.
One practical piece of advice I give patients is to slow down when eating. With Mounjaro, the signal telling you that you have had enough can arrive earlier than you are used to.
What are the common side effects of Mounjaro?
The most common side effects involve the digestive system.
These can include:
- nausea
- diarrhoea
- constipation
- vomiting
- abdominal discomfort
- indigestion
- reduced appetite
They are often more noticeable when treatment is started or when the dose is increased. In the SURMOUNT-1 trial, most gastrointestinal adverse events were mild to moderate and occurred predominantly during dose escalation.
Eating smaller meals, avoiding very fatty meals and keeping fluids up can help some people manage these symptoms.
However, persistent vomiting, severe abdominal pain or significant dehydration should not simply be put down to “normal side effects”.
When should you seek medical advice?
Severe or persistent abdominal pain needs particular attention.
Acute pancreatitis has been reported with tirzepatide, including serious cases. Patients are advised to seek immediate medical attention if they develop persistent, severe abdominal pain, particularly if it radiates through to the back. If pancreatitis is suspected, tirzepatide should be stopped and should not be restarted if the diagnosis is confirmed.
This is one of the reasons a proper medical assessment matters before and during treatment.
Who can take Mounjaro for weight loss?
Eligibility is not based on wanting to lose a few kilograms.
Under its UK marketing authorisation, Mounjaro can be used for weight management in adults with:
- a BMI of 30 kg/m² or above, or
- a BMI of 27 kg/m² or above together with at least one weight-related health condition.
Treatment should be combined with a reduced-calorie diet and increased physical activity.
A prescriber will also consider your medical history, current medicines and any factors that could make treatment unsuitable or require additional monitoring.
This is why buying a weight-loss injection without a proper clinical assessment is not something I would recommend.
Who should not take Mounjaro?
Mounjaro is not appropriate for everyone.
You should tell your prescriber if you have a history of pancreatitis, significant gastrointestinal problems, diabetes, kidney or liver problems, or if you take medicines that could interact with treatment.
Tirzepatide should not be used during pregnancy. If you are planning a pregnancy, current UK product information advises stopping tirzepatide at least one month before a planned pregnancy.
There is also an important point for women taking the oral contraceptive pill. Because tirzepatide can affect gastric emptying, reduced effectiveness of oral contraceptives cannot be excluded. Current UK advice is to use a barrier method or switch to a non-oral contraceptive for four weeks after starting Mounjaro and for four weeks after each dose increase.
If you are having surgery or a procedure requiring anaesthesia, make sure the healthcare team knows that you are taking Mounjaro.
Do you need to diet while taking Mounjaro?
Mounjaro is not a replacement for eating well.
In fact, the appetite reduction can make it easier to improve your diet because you are no longer fighting the same level of hunger.
I usually encourage patients to prioritise:
- protein-rich foods
- vegetables and other sources of fibre
- adequate fluids
- sensible portions
- regular meals rather than prolonged periods of not eating
- resistance exercise where appropriate to help support muscle mass
There is no need to starve yourself to make Mounjaro work.
Trying to eat as little as possible can leave you feeling weak and can make it harder to meet your nutritional needs. The aim is sustainable weight loss, not simply getting the lowest possible number on the scales.
Is Mounjaro a permanent treatment?
This is something worth discussing before starting rather than after you reach your target weight.
Obesity is a chronic condition, and appetite regulation does not necessarily remain permanently altered simply because you have lost weight. If treatment is stopped, appetite may increase again and some weight regain can occur.
The decision about whether to continue, reduce, stop or change treatment should therefore be made with your prescriber, taking into account your weight, health, appetite, treatment response and long-term goals.
Mounjaro should be viewed as part of a wider weight-management plan rather than a short course of injections.
What happens before starting Mounjaro?
At Direct Weight Loss, treatment starts with an assessment rather than simply selecting a pen strength.
Your medical history, current medication, weight and other relevant health information need to be considered before a prescription is issued.
If Mounjaro is appropriate, the starting dose is normally 2.5 mg once weekly, followed by gradual dose escalation according to response and tolerability.
If you are considering Mounjaro treatment, our approach is to combine the medication with professional guidance, nutrition and lifestyle support, with follow-up throughout treatment.
The bottom line: how does Mounjaro cause weight loss?
Mounjaro works because tirzepatide activates both GLP-1 and GIP receptors. This influences appetite regulation, helps you feel fuller, slows gastric emptying and improves glucose-dependent insulin responses.
For many people, the practical result is straightforward: less hunger, earlier fullness, smaller portions and fewer cravings, making it easier to maintain a calorie deficit without relying entirely on willpower.
The weight loss can be substantial. In clinical research, average losses of around 15–21% were seen over 72 weeks depending on the dose, but individual results vary considerably.
The important part is using the medicine appropriately. Mounjaro is a prescription treatment with genuine benefits, but it also has contraindications, side effects and situations where additional clinical advice is needed.
If you are considering Mounjaro for weight loss, a consultation with a qualified prescriber is the right place to start.
Medical information reviewed in line with current UK product information and regulatory guidance. Mounjaro is a prescription-only medicine and is not suitable for everyone. This article does not replace an individual consultation with a qualified healthcare professional.